University Of Miami School Of Medicine
- Image
University of Miami
The mission of the Miami Clinical and Translational Science Institute (CTSI) is to serve as the home to clinical and translational science at the University of Miami with the goals of: 1) Improving the quality and efficacy of clinical and translational research; 2) Advancing team science, and; 3) Culturalizing health sciences.
July 01, 2021Alberto Ramos, M.D., M.S.P.H., Associate Professor of Neurology, CTSI KL2 Graduate, and Research Director of the Sleep Disorders Program at the University of Miami Miller School of Medicine, was awarded a five-year $13 million grant from the National Institute on Aging to study the impact of obstructive sleep apnea on the risk of Alzheimer’s disease and other dementias in Hispanic adults.
July 01, 2021Vitamin C, an essential dietary nutrient for humans, has been touted for its immune boosting properties for more than half a century. More recently, research has revealed its greater potential as a treatment for blood cancers. In her ongoing research, Miami CTSI Pilot Award recipient and Principal Investigator Luisa Cimmino, Ph.D., explores the potential of Vitamin C to combat blood cancers such as leukemia.
-University Of Miami School Of MedicineOn July 8 from 1 to 2 p.m., as The Miami Clinical and Translational Science Institute (CTSI) will host four Principal Investigators from the University of Miami for a virtual presentation to discuss the challenges and barriers as well as the strategies and best practices for recruiting underrepresented minorities into their various clinical research studies.
-University Of Miami School Of MedicineKL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Chandylen Nightingale, PhD, MPH from the Wake Forest School of Medicine, hosted by the University of Miami School of Medicine will present her research on “Examining Capacity in Community Oncology and Moving the Needle to Improve Supportive Care Delivery for
Focal and Segmental Glomerulosclerosis, Minimal Change Disease and Membranous Nephropathy, presenting as Nephrotic Syndrome (NS), are a group of rare renal diseases that may cause serious complications and end-stage kidney disease, generating significant individual, societal and economic burdens. The Nephrotic Syndrome Study Network (NEPTUNE) brings together physician scientists at 26 sites in the
Charcot-Marie-Tooth disease (CMT) is one of the most common inherited neurological disorders, affecting approximately 1 in 2,500 people in the United States. CMT, also known as hereditary motor and sensory neuropathy or peroneal muscular atrophy, comprises a group of disorders that affect peripheral nerves. The Inherited Neuropathy Consortium (INC) is a network of researchers working to find the
Amyotrophic lateral sclerosis (ALS) is a fatal disease that involves progressive death of motor nerves in the brain, brainstem and spinal cord. The disease is closely related to disorders such as primary lateral sclerosis, hereditary spastic paraplegia, progressive muscular atrophy and frontotemporal dementia. These diseases have shared genetic causes and underlying biology. They also have in
University Of Miami School Of MedicineThe COVID-19 pandemic, while a significant disruptive event for research, resulted in a novel focus area for clinical and translational (C/T) researchers. Miami CTSI rapidly responded to this critical need by leading a collaborative effort to facilitate COVID-19 research and education initiatives for researchers and community stakeholders, while implementing innovative solutions to continue other
-
University Of Miami School Of Medicine
The COVID-19 pandemic, while a significant disruptive event for research, resulted in a novel focus area for clinical and translational (C/T) researchers. Miami CTSI rapidly responded to this critical need by leading a collaborative effort to facilitate COVID-19 research and education initiatives for researchers and community stakeholders, while implementing innovative solutions to continue other
July 21, 2020One of the first synergy papers supported by the CLIC and CTSA consortium was published in the Journal of Clinical and Translational Science. Abstract: A primary barrier to translation of clinical research discoveries into care delivery and population health is the lack of sustainable infrastructure bringing researchers, policymakers, practitioners, and communities together to reduce silos in
University Of North Carolina Chapel HillUniversity Of Miami School Of MedicineVirginia Commonwealth UniversityReGARDD provides academic researchers with the regulatory tools and resources necessary to successfully navigate the pathway from discovery to clinical implementation of new drugs, biologics and medical devices.
-
-University Of Miami School Of Medicine
Please join the University of Miami CTSI for its next Translational Tuesday webinar, a weekly webinar series highlighting UM's top ongoing research and innovations for COVID-19. This webinar will feature a virtual presentation and Q&A with Dr. Natasa Strbo, who will provide a timely overview on efforts to develop a vaccine for the 2019 novel coronavirus SARS-CoV-2, the causative agent of
-University Of Miami School Of MedicinePlease join us on April 14 at 10 a.m., for Miami CTSI's Translational Tuesday, an online presentation and Q&A with Dr. Erin Kobetz and Dr. Natasha Schaefer Solle, of the University of Miami, who will discuss a new testing effort in collaboration with Miami-Dade County to assess the prevalence of COVID-19 infection in the local community.
The OneFlorida Clinical Research Consortium represents a strategic integration and expansion of CTSA hub partnerships throughout Florida to create a statewide infrastructure for patient-centered research in diverse health care settings. Consortium partners include the University of Florida, Florida State University, University of Miami and affiliated health care systems, health plans, providers
-
University Of North Carolina Chapel HillDuke UniversityWake Forest University Health SciencesMedical University Of South CarolinaUniversity Of Miami School Of MedicineVirginia Commonwealth UniversityReGARDD provides academic researchers with the regulatory tools and resources necessary to successfully navigate the pathway from discovery to clinical implementation of new drugs, biologics and medical devices. Investigational New Drug or Biologic Investigational Device Exemption Educational Videos ReGARDD Sponsored Events Who We Are The Regulatory Guidance for Academic Research of Drugs and
The Division of Epidemiology in the Department of Public Health Sciences at the University of Miami is seeking an exceptional candidate for a full-time Associate/Full Professor position who will develop and consolidate a University-wide program in the Epidemiology of Non Communicable Diseases (NCD), in alignment with the Miller School of Medicine research strategic priorities, taking advantage of the intellectual capital throughout the University that addresses the unique diversity of our populations and South Florida's unique location as the gateway to Latin America and the Caribbean.
